The LLS Blog
Read about survivors, research, fundraising and advocacy.
LLS and UFCW: Fighting Cancer Together
Cancer will not wait for COVID-19 to go away. And blood cancer patients can’t wait either. In fact, they need support now, more than ever. Because of dedicated volunteers and partners like United Food & Commercial Workers International Union (UFCW), LLS is still able to carry out our lifesaving work in communities across the country, even amidst a global pandemic.
FDA Approves New Maintenance Treatment for AML
Some promising news to kick off Blood Cancer Awareness Month – on September 1, 2020, the U.S. Food and Drug Administration approved a new oral maintenance treatment for certain adult patients with acute myeloid leukemia (AML).
Driving Forward our COVID-19 Policy Priorities for Patients
430,000 people – it’s a huge number. It’s the population of Minneapolis. Nine straight days of sell-out crowds at Yankee Stadium. Nearly the entire enrollment of the Southeastern Conference. And it’s the number of people who, in the last six weeks, have become newly eligible for Medicaid, thanks to successful ballot initiatives this summer in Oklahoma and Missouri. LLS, our staff, and our volunteers are proud to have played a role in this major win for patients.
An Emerging Target for Myeloma Therapy Could Prove a Game-Changer
When the Insurance Says No to a Clinical Trial
As an LLS Clinical Trial Nurse Navigator, Ashley Giacobbi works tirelessly to connect the right patient with the right clinical trial – work that has become increasingly complicated in the COVID-19 era. But recently, she went the extra mile to ensure a patient – a young healthcare worker whose AML had relapsed several times – could access a trial that offered a promising treatment option.